Evoke Pharma (EVOK) Misses Q3 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. CDNS
2. AVGO
3. SPY
4. META
5. JBLU
6. ANT
7. AAPL
8. SSD
9. ARTV
10. AGYS

Go back to Evoke Pharma (EVOK) Misses Q3 EPS by 3c

Evoke Pharma Reports Third Quarter 2016 Results

November 9, 2016 4:06 PM EST

SOLANA BEACH, Calif., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financial results for the third quarter ended September 30, 2016.

Dave Gonyer, R.Ph., President and CEO, stated, The third quarter was a very active time for Evoke. After receiving results from our Phase 3 clinical trial of Gimoti for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women, we began extensive data analysis to better understand the outcome. We... More